Skip to main content

Advertisement

SpringerLink
Log in

Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence

  • Psoriatic Arthritis (O FitzGerald and P Helliwell, Section Editors)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Psoriatic arthritis (PsA), a chronic inflammatory arthritis, affects about 10 % of patients with psoriasis with higher prevalence seen in patients with more extensive skin disease. Early identification of PsA may result in improved outcomes. While it remains unclear which patients with psoriasis will develop PsA, several studies have identified potential risk factors for PsA among patients with psoriasis. This review examines the basic epidemiologic principles of identifying risk factors and reviews the evidence to date about risk factors for PsA among patients with psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently have been highlighted as: • Of importance •• Of major importance

  1. Kurd S, Gelfand J. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60(2):218–24.

    Article  PubMed  Google Scholar 

  2. Alamanos Y, Voulgari P, Drosos A. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008;35(7):1354–8.

    PubMed  Google Scholar 

  3. Ibrahim G, Waxman R, Helliwell P. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009;61(10):1373–8.

    Article  CAS  PubMed  Google Scholar 

  4. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573.

    PubMed  Google Scholar 

  5. Ogdie A, Langan S, Love T, et al. Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford). 2013;52(3):568–75.

    Article  Google Scholar 

  6. Mease P, Gladman D, Papp K, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–35.

    Article  PubMed  Google Scholar 

  7. Fitzgerald O, Haroon M, Giles JT, Winchester R. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015;17(1):115. While our review discusses the clinical risk factors for PsA, this is an excellent review of the genetic risk factors for psoriatic arthritis and the interplay between genotypes and phenotypes in psoriatic arthritis.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Fletcher RH, Fletcher SW, Fletcher GS. Risk: basic principles. In: clinical epidemiology: the essentials. 5th ed. Baltimore: Lippincott Williams & Wilkins; 2014. p. 50–79.

    Google Scholar 

  9. Simon L. Pharmacovigilance: towards a better understanding of the benefit to risk ratio. Ann Rheum Dis. 2002;61(2):ii88–9.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.

    PubMed Central  CAS  PubMed  Google Scholar 

  11. Ogdie A, Weiss PF. Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am 2015; In Press.

  12. Wu S, Han J, Qureshi AA. Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study. Acta Derm Venereol. 2015;95(2):217–23.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Wu S, Li WQ, Han J, Sun Q, Qureshi AA. Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women. Arthrit Rheumatol. 2014;66(2):304–10. In this retrospective cohort study, Wu et al. found an increased incidence of both psoriasis and psoriatic arthritis among patients with physician-diagnosed hypercholesterolemia. In contrast, there was no association with cholesterol-lowering medications.

    Article  CAS  Google Scholar 

  14. Tong LX, Wu S, Li T, Qureshi AA, Giovannucci EL, Cho E. Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women. Br J Dermatol. 2015;172(5):1316–22.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736–40.

    Article  PubMed  Google Scholar 

  16. Gelfand J, Gladman D, Mease P, et al. Epidemiology of psoriatic arthritis in the population of the US. 2005; 53:573–7.

  17. Wilson F, Icen M, Crowson C, McEvoy M, Gabriel S, Kremers H. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Soltani-Arabshahi R, Wong B, Feng B, Goldgar D, Duffin K, Krueger G. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol. 2010;146(7):721–6.

    Article  PubMed  Google Scholar 

  19. Tey H, Ee H, Tan A, Theng T, Wong S, Khoo S. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol. 2010;37(5):426–30.

    Article  PubMed  Google Scholar 

  20. Anandarajah A, Ritchlin C. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol. 2004;16(4):338–43.

    Article  CAS  PubMed  Google Scholar 

  21. Ferrándiz C, Pujol RM, García-Patos V, Bordas X, Smandía JA. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002;46(6):867–73.

    Article  PubMed  Google Scholar 

  22. Stuart P, Malick F, Nair RP, et al. Analysis of phenotypic variation in psoriasis as a function of age at onset and family history. Arch Dermatol Res. 2002;294(5):207–13.

    Article  PubMed  Google Scholar 

  23. McGonagle D, Palmou Fontana N, Tan A, Benjamin M. Nailing down the genetic and immunological basis for psoriatic disease. Dermatology. 2010;221 Suppl 1:15–22.

    Article  CAS  PubMed  Google Scholar 

  24. Love T, Gudjonsson J, Valdimarsson H, Gudbjornsson B. Psoriatic arthritis and onycholysis—results from the cross-sectional Reykjavik psoriatic arthritis study. J Rheumatol. 2012;39(7):1441–4.

    Article  PubMed  Google Scholar 

  25. Scarpa R, Soscia E, Peluso R, et al. Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol. 2006;33(7):1315–9.

    PubMed  Google Scholar 

  26. Thumboo J, Uramoto K, Shbeeb M, et al. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol. 2002;29(4):757–62.

    PubMed  Google Scholar 

  27. Thijssen E, van Caam A, van der Kraan P. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue anddyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford). 2015;54(4):588–600.

    Article  Google Scholar 

  28. Kumar S, Han J, Li T, Curhan G, Choi HK, Qureshi AA. Obesity, waist circumference, weight change, and the risk of psoriasis in US women. J Eur Acad Dermatol Venereol. 2013;27(10):1293–8.

    PubMed Central  CAS  PubMed  Google Scholar 

  29. Love T, Zhu Y, Zhang Y, et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis. 2012;71(8):1273–7.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Li W, Han J, Qureshi A. Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(8):1267–772.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Ogdie A, Gelfand JM. Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need. Arch Dermatol. 2010;146(7):785–8.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Setty A, Curhan G, Choi H. Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am J Med. 2007;120(11):953–9.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69(1):70–81.

    Article  CAS  PubMed  Google Scholar 

  34. Eder L, Shanmugarajah S, Thavaneswaran A, et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2012;71(2):219–24.

    Article  PubMed  Google Scholar 

  35. Eder L, Law T, Chandran V, et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken). 2011;63(8):1091–7.

    Article  Google Scholar 

  36. Pattison E, Harrison B, Griffiths C, Silman A, Bruce I. Environmental risk factors for the development of psoriatic arthritis: results from a case–control study. Ann Rheum Dis. 2008;67(5):627–6.

    Google Scholar 

  37. Li W, Han J, Qureshi A. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(6):804–8.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Wu S, Cho E, Li WQ, Han J, Qureshi AA. Alcohol intake and risk of incident psoriatic arthritis in women. J Rheumatol. 2015;42(5):835–40.

    Article  PubMed  Google Scholar 

  39. Scott I, Tan R, Stahl D, Steer S, Lewis C, Cope A. The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52(5):856–67.

    Article  CAS  Google Scholar 

  40. McGonagle D, Ash Z, Dickie L, McDermott M, Aydin S. The early phase of psoriatic arthritis. Ann Rheum Dis. 2011;70 Suppl 1:i71–6.

    Article  CAS  PubMed  Google Scholar 

  41. Manasson J, Scher J. Spondyloarthritis and the microbiome: new insights from an ancient hypothesis. Curr Rheumatol Rep. 2015;17(2):10. This review paper highlights the potential role of the microbiome (both the intestinal and skin microbiome) in the development of the spondyloarthropathies.

    Article  PubMed  Google Scholar 

  42. Eder L, Chandran V, Shen H. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken). 2011;63(4):619–22. Describes the first prospective longitudinal study to examine the incidence of PsA among patients with psoriasis.

    Article  Google Scholar 

Download references

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Alexis Ogdie declares no competing interests.

JM Gelfand declares the receipt of grants from Abbvie, Novartis, Pfizer, and Janssen, as well as personal fees from Abbvie, Amgen, Novartis, Pfizer, Janssen, Merck, and Coherus, outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the authors.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 5 White Room 5024, 3400 Spruce St., Philadelphia, PA, 19104, USA

    Alexis Ogdie

  2. Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, 8th Floor Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104, USA

    Alexis Ogdie & J. M. Gelfand

  3. Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 1108 Dulles, 3600 Spruce Street, Philadelphia, PA, 19104, USA

    J. M. Gelfand

Authors
  1. Alexis Ogdie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. M. Gelfand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexis Ogdie.

Additional information

This article is part of the Topical Collection on Psoriatic Arthritis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ogdie, A., Gelfand, J.M. Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence. Curr Rheumatol Rep 17, 64 (2015). https://doi.org/10.1007/s11926-015-0540-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-015-0540-1

Keywords

Search

Navigation